Skip to content

Acute Effects of Endurance Exercise on Breast Milk Composition in Women With Overweight/Obesity

Acute Effects of Endurance Exercise With Moderate and High Intensity on Breast Milk Composition Among Women With Overweight/Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05745922
Acronym
YT
Enrollment
32
Registered
2023-02-27
Start date
2023-03-01
Completion date
2025-05-20
Last updated
2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Milk Collection, Overweight and Obesity

Keywords

Exercise

Brief summary

The investigators will determine the acute effect of exercise on breastmilk composition. Participants will come in to the lab on three different days, out of which they will exercise on two of these days and rest in the lab on the third day. The conditions will be randomly allocated to each participant. Breastmilk samples will be obtained in the morning of each test day, as well as immediately after, one hour after and four hours after the exercise/rest condition. Dietary intake will be standardized on the test days.

Interventions

Treadmill walking/running with moderate intensity

BEHAVIORALHigh intensity exercise

Treadmill walking/running with high intensity

Sponsors

St. Olavs Hospital
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Masking description

The personnel who will be analysing the milk samples will be blinded to which condition the samples were obtained from and the time-point.

Intervention model description

Sequential assignment

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 6 weeks postpartum * Exclusively breastfeeding * Term birth * Singleton baby

Exclusion criteria

* Known cardiovascular disease * Known type 1 or type 2 diabetes * Limited ability to exercise

Design outcomes

Primary

MeasureTime frameDescription
Breastmilk metabolite compositionChange from before exercise to after exercise (+0 hour, +1 hour, and +4 hours)Global metabolomics profiling using MS/MS technology

Secondary

MeasureTime frameDescription
AdiponectinChange from before exercise to after exercise (+0 hour, +1 hour, and +4 hours)Concentration
LeptinChange from before exercise to after exercise (+0 hour, +1 hour, and +4 hours)Concentration
Insulin Growth Factor-1Change from before exercise to after exercise (+0 hour, +1 hour, and +4 hours)Concentration
InsulinChange from before exercise to after exercise (+0 hour, +1 hour, and +4 hours)Concentration
GhrelinChange from before exercise to after exercise (+0 hour, +1 hour, and +4 hours)Concentration
Cytokine profiling (Multiplex 27)Change from before exercise to after exercise (+0 hour, +1 hour, and +4 hours)Concentration
Complex lipids compositionChange from before exercise to after exercise (+0 hour, +1 hour, and +4 hours)Global metabolomics profiling using MS/MS technology

Other

MeasureTime frameDescription
Fat mass in kgAt baselineImpedance scale
Muscle mass in kgAt baselineImpedance scale
Height in metresAt baselineStadiometer
Body mass in kgAt baselineImpedance scale
Cardiorespiratory fitnessAt baselinePeak oxygen uptake

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026